ASCO 2025: Instil Bio CEO Bronson Crouch discusses the company's PD1 x VEGF, and shares a quick take on this morning's competitor news
May 30, 2025
09:58
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
He offers what he believes are learnings from this morning's data, and describes the data Instil's partner ImmuneOnco has derived for their asset to date. Plus, plans for future data later this year and getting a U.S. study up and running.
BiotechTV - News